Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 REMARKS OF PRESIDENT - LIBERATOR MEDICAL HOLDINGS, INC. | f8k102014_ex99z1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 20, 2014
LIBERATOR MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
NEVADA |
| 000-05663 |
| 87-0267292 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification Number) |
2979 SE Gran Park Way, Stuart, Florida 34997
(Address of Principal Executive Offices)
(772) 287-2414
(Registrant’s telephone number, including area code)
_________________________________
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
.Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
.Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
.Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
.Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07
Submission of Matters to a Vote of Security Holders
On October 20, 2014, Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), held its annual meeting of stockholders to (i) elect directors; (ii) ratify the appointment of its independent registered public accounting firm; (iii) provide a non-binding advisory vote on executive compensation; and (iv) frequency of non-binding advisory vote on compensation of named executive officers. A majority of the stockholders entitled to vote at the annual meeting were present at the annual meeting in person or by proxy. The following table shows the number of votes cast for, against, abstentions, and the number of broker non-votes on each matter.
Election of Directors: | For | Against | Withheld | Broker Non-Vote |
Mark A. Libratore | 29,697,880 | 0 | 113,385 | 9,466,156 |
Jeannette Corbett | 29,653,212 | 0 | 158,053 | 9,466,156 |
Tyler Wick | 29,667,366 | 0 | 143,899 | 9,466,156 |
Ratification of |
|
|
|
Public Accountants: | For | Against | Abstain |
Crowe Horwath LLP | 38,090,414 | 403,481 | 783,526 |
Non-Binding Advisory Vote |
|
|
|
|
On Compensation of Named |
|
|
| Broker |
Executive Officers: | For | Against | Abstain | Non-Vote |
| 28,181,340 | 360,142 | 1,269,783 | 9,466,156 |
Frequency of Non-Binding |
|
|
|
|
Advisory Vote on Compensation |
|
|
|
|
Of Named Executive Officers: | One Year | Two Years | Three Years | Abstain |
| 4,193,075 | 292,798 | 23,967,098 | 1,358,294 |
Item 8.01
Other Events
On October 20, 2014, Mark A. Libratore, the Company’s President and Chief Executive Officer, addressed the stockholders at the Company’s annual meeting of stockholders in Stuart, Florida. Mr. Libratore’s remarks are filed as Exhibit 99.1 to this Report on Form 8-K.
The information under this caption, “Item 8.01 – Other Events,” including information in any related exhibits, is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that Section. This information shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
2
Item 9.01
Financial Statements and Exhibits
(d)
Exhibits
Exhibit No. | Description |
|
|
99.1 | Remarks of President and Chief Executive at the Company’s Annual |
| Stockholders Meeting on October 20, 2014. |
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
LIBERATOR MEDICAL HOLDINGS, INC.
Registrant
Dated: October 20, 2014
/s/ Mark A. Libratore
Mark A. Libratore, President
4